ICD-10 Coding for Malignant Neoplasm of Liver(C22.0, C22.0B, C22.0D)
Explore comprehensive ICD-10 coding guidelines for malignant neoplasm of liver, including primary and secondary liver cancer codes.
Complete code families applicable to Malignant Neoplasm of Liver
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C22.0 | Hepatocellular carcinoma | Use when hepatocellular carcinoma is confirmed by biopsy or supported by imaging and lab findings. |
|
| C78.7 | Secondary malignant neoplasm of liver | Use when liver cancer is secondary to another primary cancer. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMalignant Neoplasm of Liver
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Malignant Neoplasm of Liver.
Documenting 'liver cancer' without specifying primary or secondary
Impact
Clinical: May lead to inappropriate treatment plans., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation
Always specify the origin of the cancer., Use clear terminology in documentation.
Using C22 codes for metastatic liver cancer
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate cancer registry data.
Mitigation
Use C78.7 for secondary liver cancer and code the primary site first.
Primary vs. Secondary Cancer Coding
Impact
Incorrectly coding metastatic liver cancer as primary.
Mitigation
Implement training on proper sequencing and documentation.